A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A

被引:27
|
作者
Wu, Yuanzhong [1 ]
Zhou, Liwen [1 ]
Wang, Xin [1 ]
Lu, Jinping [2 ,3 ]
Zhang, Ruhua [1 ]
Liang, Xiaoting [1 ]
Wang, Li [1 ]
Deng, Wuguo [1 ]
Zeng, Yi-Xin [1 ]
Huang, Haojie [1 ,4 ]
Kang, Tiebang [1 ,5 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Clin Lab, Zhuhai, Peoples R China
[3] Jinan Univ, Med Res Ctr, Zhuhai, Peoples R China
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA
[5] Guangzhou Doublle Bioprod Co Ltd, Guangdong Prov Key Lab Tumor Targeted Drugs, Guangzhou, Guangdong, Peoples R China
关键词
acetylation; Cdc25A; CRISPR-Cas9; screening; protein stability; ubiquitination; SCF UBIQUITIN LIGASE; BETA-TRCP; DEGRADATION; CELLS; NETWORKS; INSIGHTS;
D O I
10.1038/celldisc.2016.14
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of stability is particularly crucial for unstable proteins in cells. However, a convenient and unbiased method of identifying regulators of protein stability remains to be developed. Recently, a genome-scale CRISPR-Cas9 library has been established as a genetic tool to mediate loss-of-function screening. Here, we developed a protein stability regulators screening assay (Pro-SRSA) by combining the whole-genome CRISPR-Cas9 library with a dual-fluorescence-based protein stability reporter and high-throughput sequencing to screen for regulators of protein stability. Using Cdc25A as an example, Cul4B-DDB1DCAF8 was identified as a new E3 ligase for Cdc25A. Moreover, the acetylation of Cdc25A at lysine 150, which was acetylated by p300/CBP and deacetylated by HDAC3, prevented the ubiquitin-mediated degradation of Cdc25A by the proteasome. This is the first study to report that acetylation, as a novel posttranslational modification, modulates Cdc25A stability, and we suggest that this unbiased CRISPR-Cas9 screening method at the genome scale may be widely used to globally identify regulators of protein stability.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Protein stability regulators screening assay(Pro-SRSA):protein degradation meets the CRISPR-Cas9 library
    Yuanzhong Wu
    Tiebang Kang
    Chinese Journal of Cancer, 2016, 35 (08) : 385 - 387
  • [32] Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR-Cas9 library
    Wu, Yuanzhong
    Kang, Tiebang
    CHINESE JOURNAL OF CANCER, 2016, 35
  • [33] Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance (vol 7, 359, 2021)
    Lu, Yonggang
    Shen, Haoming
    Huang, Wenjie
    He, Sha
    Chen, Jianlin
    Zhang, Di
    Shen, Yongqi
    Sun, Yifan
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [34] Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens
    Zhao, Yichao
    Tabet, Daniel
    Contreras, Diana Rubio
    Lao, Linjiang
    Kousholt, Arne Nedergaard
    Weile, Jochen
    Melo, Henrique
    Hoeg, Lisa
    Feng, Sumin
    Cote, Atina G.
    Lin, Zhen-Yuan
    Setiaputra, Dheva
    Jonkers, Jos
    Gingras, Anne -Claude
    Gomez Herreros, Fernando
    Roth, Frederick P.
    Durocher, Daniel
    MOLECULAR CELL, 2023, 83 (15) : 2792 - +
  • [35] Identification of BRAF Inhibitor Resistance-associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening
    Wen, Xuan
    Han, Min
    Hosoya, Masaki
    Toshima, Rika
    Onishi, Mai
    Fujii, Tomoaki
    Yamaguchi, Shigeo
    Kato, Shunsuke
    ANTICANCER RESEARCH, 2024, 44 (06) : 2349 - 2358
  • [36] Genome-Scale CRISPR-Cas12a Screen Identifies Novel Fetal Hemoglobin Regulators
    Traxler, Elizabeth A.
    Komar, Chad
    Saari, Megan
    Thrasher, A. Josephine
    Qin, Kunhua
    Khandros, Eugene
    Hotan, Quynn
    Abdulmalik, Osheiza
    Shao, Claire
    Chen, Qingzhou
    Minn, Andy J.
    Keller, Cheryl A.
    Shi, Junwei
    Blobel, Gerd A.
    BLOOD, 2023, 142
  • [37] Determining antigen specificity of a monoclonal antibody using genome-scale CRISPR-Cas9 knockout library
    Zotova, Anastasia
    Zotov, Ivan
    Filatov, Alexander
    Mazurov, Dmitriy
    JOURNAL OF IMMUNOLOGICAL METHODS, 2016, 439 : 8 - 14
  • [38] Identification of novel regulators of cross-presentation with CRISPR-Cas9
    Theisen, D.
    Davidson, J.
    Briseno, C. G.
    Gargaro, M.
    Wang, Q.
    Lauron, E.
    Bagadia, P.
    Durai, V
    Sibley, D.
    Gillanders, W.
    Schreiber, R.
    Murphy, T.
    Murphy, K. M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 28 - 28
  • [39] A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine
    Masoudi, Mohammad
    Seki, Motoaki
    Yazdanparast, Razieh
    Yachie, Nozomu
    Aburatani, Hiroyuki
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells
    Li, Miao
    Zhang, Chang-lin
    Zhou, Di-sheng
    Chan, Sze-Hoi
    Liu, Xue-Qi
    Chen, Shu-Na
    Yang, Zi-Yi
    Ju, Fei-er
    Sang, Xiao-yan
    Liu, Zi-xuan
    Zhang, Qiao-Xia
    Pan, Yu-ming
    Deng, Si-si
    Wang, Xiao-Mei
    Zhong, Li
    Zhang, Xing-Ding
    Du, Xin
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1307 - 1324